| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2023 | APTITUDE MEDICAL SYSTEMS INC | 125 CREMONA DR | GOLETA | CA | 93117-3083 | SANTA BARBARA | USA | R44EY030822 | Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases | 000 | 3 | NIH | 10/17/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = -$4,193 ) |
| 2024 | 2022 | APTITUDE MEDICAL SYSTEMS INC | 125 CREMONA DR | GOLETA | CA | 93117-3083 | SANTA BARBARA | USA | R44EY033265 | Developing multi-specific aptamers for safe, potent, and long-lasting treatment of geographic atrophy | 000 | 1 | NIH | 11/8/2023 | $0 |
| 2024 | 2021 | APTITUDE MEDICAL SYSTEMS INC | 125 CREMONA DR | GOLETA | CA | 93117-3083 | SANTA BARBARA | USA | R44EY032438 | Developing a multivalent agent for long-lasting treatment of diabetic macular edema | 000 | 1 | NIH | 2/9/2024 | -$4,193 |
| 2024 | 2021 | APTITUDE MEDICAL SYSTEMS INC | 125 CREMONA DR | GOLETA | CA | 93117-3083 | SANTA BARBARA | USA | R44EY030828 | Targeting SDF-1 for effective wet AMD treatment | 000 | 3 | NIH | 1/2/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $755,521 ) |
| 2023 | 2023 | APTITUDE MEDICAL SYSTEMS INC | 125 CREMONA DR | GOLETA | CA | 93117-3083 | SANTA BARBARA | USA | R44EY030822 | Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases | 000 | 3 | NIH | 4/27/2023 | $755,521 |
|
| Issue Date FY: 2022 ( Subtotal = $992,034 ) |
| 2022 | 2022 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44EY030822 | Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases | 000 | 2 | NIH | 5/16/2022 | $744,393 |
| 2022 | 2022 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44EY033265 | Developing multi-specific aptamers for safe, potent, and long-lasting treatment of geographic atrophy | 000 | 1 | NIH | 6/16/2022 | $247,641 |
| 2022 | 2020 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44EY030822 | Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases | 001 | 1 | NIH | 7/12/2022 | $0 |
| 2022 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44GM123822 | Scalable High Quality Aptamer Generation via Chemically-Augmented Particle Display | 000 | 3 | NIH | 11/7/2021 | $0 |
| 2022 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R43EY029960 | Targeting PDGFs for Potential Treatment of Proliferative Vitreoretinopathy | 000 | 1 | NIH | 2/16/2022 | $0 |
| 2022 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44DK101280 | Real-time Point of Care Insulin Monitoring Device for Improved Diabetes Management | 000 | 3 | NIH | 11/27/2021 | $0 |
| 2022 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R43EB026362 | Topical delivery of therapeutic aptamers | 000 | 1 | NIH | 2/17/2022 | $0 |
| 2022 | 2017 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R43EB025095 | Next-generation aptamers for faster, safer, more sensitive in vivo PET imaging | 000 | 1 | NIH | 11/13/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,029,870 ) |
| 2021 | 2021 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44EY032438 | Developing a multivalent agent for long-lasting treatment of diabetic macular edema | 000 | 1 | NIH | 8/10/2021 | $224,653 |
| 2021 | 2021 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R44EY030828 | Targeting SDF-1 for effective wet AMD treatment | 000 | 3 | NIH | 7/28/2021 | $805,217 |
| 2021 | 2020 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44EY030822 | Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases | 000 | 1 | NIH | 4/12/2021 | $0 |
| 2021 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R43AI142977 | Aptamer-enabled multiplex electrochemical sensor for robust and efficient assessment of flu vaccine potency | 000 | 1 | NIH | 6/28/2021 | $0 |
| 2021 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R43HL144259 | Point-of-care testing of fibrinogen for early detection and management of trauma coagulopathy | 000 | 1 | NIH | 12/9/2020 | $0 |
| 2021 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 125 CREMONA DR # 100 | GOLETA | CA | 93117-5503 | SANTA BARBARA | USA | R43EY029650 | Sustained release of next-generation aptamers to treat wet AMD | 000 | 1 | NIH | 5/3/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,136,671 ) |
| 2020 | 2020 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44EY030822 | Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases | 000 | 1 | NIH | 2/21/2020 | $224,973 |
| 2020 | 2020 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44EY030828 | Targeting SDF-1 for effective wet AMD treatment | 002 | 2 | NIH | 7/27/2020 | $911,698 |
| 2020 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44EY030828 | Targeting SDF-1 for effective wet AMD treatment | 001 | 1 | NIH | 6/9/2020 | $0 |
| 2020 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43AI142977 | Aptamer-enabled multiplex electrochemical sensor for robust and efficient assessment of flu vaccine potency | 000 | 1 | NIH | 2/21/2020 | $0 |
| 2020 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44EY030828 | Targeting SDF-1 for effective wet AMD treatment | 000 | 1 | NIH | 4/16/2020 | $0 |
| 2020 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EB026362 | Topical delivery of therapeutic aptamers | 000 | 1 | NIH | 9/23/2020 | $0 |
| 2020 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44DK101280 | Real-time Point of Care Insulin Monitoring Device for Improved Diabetes Management | 000 | 3 | NIH | 7/1/2020 | $0 |
| 2020 | 2017 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EB025095 | Next-generation aptamers for faster, safer, more sensitive in vivo PET imaging | 000 | 1 | NIH | 6/30/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,264,749 ) |
| 2019 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44GM123822 | Scalable High Quality Aptamer Generation via Chemically-Augmented Particle Display | 000 | 3 | NIH | 5/30/2019 | $534,143 |
| 2019 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EY029960 | Targeting PDGFs for Potential Treatment of Proliferative Vitreoretinopathy | 000 | 1 | NIH | 9/13/2019 | $224,946 |
| 2019 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44EY030828 | Targeting SDF-1 for effective wet AMD treatment | 000 | 1 | NIH | 9/17/2019 | $282,661 |
| 2019 | 2019 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43AI142977 | Aptamer-enabled multiplex electrochemical sensor for robust and efficient assessment of flu vaccine potency | 000 | 1 | NIH | 3/14/2019 | $222,999 |
| 2019 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EY029650 | Sustained release of next-generation aptamers to treat wet AMD | 000 | 1 | NIH | 11/14/2018 | $0 |
| 2019 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EB026362 | Topical delivery of therapeutic aptamers | 000 | 1 | NIH | 12/18/2018 | $0 |
| 2019 | 2017 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EB025095 | Next-generation aptamers for faster, safer, more sensitive in vivo PET imaging | 000 | 1 | NIH | 6/12/2019 | $0 |
| 2019 | 2017 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EB025095 | Next-generation aptamers for faster, safer, more sensitive in vivo PET imaging | 001 | 1 | NIH | 6/17/2019 | $0 |
| 2019 | 2017 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EY028494 | Targeting SDF-1 for effective wet AMD treatment | 000 | 1 | NIH | 2/15/2019 | $0 |
| 2019 | 2016 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43HL133305 | Aptamer-Enabled High-sensitivity Troponin assay for rapid POC diagnosis of myocardial infarction | 000 | 1 | NIH | 2/7/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $2,599,287 ) (Continued on the next page) |
| 2018 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44DK101280 | Real-time Point of Care Insulin Monitoring Device for Improved Diabetes Management | 000 | 3 | NIH | 5/21/2018 | $640,326 |
| 2018 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44GM123822 | Scalable High Quality Aptamer Generation via Chemically-Augmented Particle Display | 001 | 2 | NIH | 6/4/2018 | $918,746 |
| 2018 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44GM123822 | Scalable High Quality Aptamer Generation via Chemically-Augmented Particle Display | 002 | 2 | NIH | 9/7/2018 | $0 |
| 2018 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R44GM123822 | Scalable High Quality Aptamer Generation via Chemically-Augmented Particle Display | 003 | 2 | NIH | 9/10/2018 | $227,400 |
| 2018 | 2018 | APTITUDE MEDICAL SYSTEMS, INC. | 2219 BATH ST | SANTA BARBARA | CA | 93105-4321 | SANTA BARBARA | USA | R43EB026362 | Topical delivery of therapeutic aptamers | 000 | 1 | NIH | 9/22/2018 | $293,239 |
|